TrialAnnals of surgery1999

Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

T K Rosengart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.